Patent Strategy
Protecting our innovative approach to stroke detection through retinal imaging
Historical Foundation
Our patent strategy builds upon foundational research that first established the connection between retinal imaging and cardiovascular health. The scientific basis for our approach dates back over 20 years to pioneering work in the field.
Original Research Foundation (1999)
The first scientific association between fundus imaging and cardiovascular risk was established in 1999 by L. D. Hubbard et al. in their landmark study:
This foundational research demonstrated that retinal microvascular changes visible in fundus images could serve as indicators of systemic cardiovascular conditions, including stroke risk.
Expired Patent Reference
Stroke Fundus Patent (EP14025012)
A key patent in this field, EP14025012, which covered stroke detection through fundus imaging, has expired 3 years ago.
This patent, which was over 20 years old, represented an early attempt to commercialize the connection between retinal imaging and stroke risk assessment. Its expiration opens new opportunities for innovation in this space.
Key Points:
- The patent was based on the 1999 research by Hubbard et al. that first associated fundus imaging with cardiovascular risk
- It expired approximately 3 years ago, creating a window for new approaches
- The patent was over 20 years old, reflecting the long-standing scientific foundation of this field
- Our strategy leverages modern AI and machine learning technologies that were not available when the original patent was filed
Our Innovation
While building upon the scientific foundation established in 1999, eyemap.ai brings significant innovations:
- AI-Powered Analysis: Advanced machine learning models that can detect subtle patterns invisible to the human eye
- Multi-Pathology Detection: Simultaneous screening for stroke, diabetes, cardiovascular disease, and other conditions
- Accessibility: Works with smartphone cameras, making screening available in optical shops rather than requiring specialized medical facilities
- Real-Time Processing: Instant results during routine eye examinations
- Large-Scale Dataset: Access to 68,000 fundus images specifically curated for stroke risk assessment
Patent Strategy
Our comprehensive patent strategy (details shared under NDA) focuses on protecting:
- Novel AI algorithms and model architectures for multi-pathology detection
- Integration methods for combining retinal imaging with clinical data
- Real-time processing and analysis systems
- Mobile and accessible screening platforms
- Data processing and validation methodologies
For detailed information about our patent strategy and filing timeline, please contact us under NDA.
← Back to Home